ROS1 and non-small cell lung carcinoma: Hence, plasma analysis of 171 NSCLC patients was performed using a sensitive NGS assay that analyses hotspot regions of 12 genes frequently altered in NSCLC and fusions in ALK, ROS1 and RET genes.